Clinical Trials

20 enrolled

Plasma cell

Recurrence, Neoplasms, Plasma Cell

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

LymphoidOther hematologic neoplasm

12 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07113496 2025-08-13

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Phase 1 Not yet recruiting

27 enrolled

LymphoidPlasma cell

Plasmablastic Lymphoma, Burkitt Lymphoma, Multiple Myeloma, Recurrence

NCT07097948 2025-08-01

Adjuvant

40 enrolled

Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT07098949 2025-08-01

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

346 enrolled

Recurrence, Stomach Neoplasms

NCT07077330 2025-07-22

CAR19BCMA

20 enrolled

Plasma cell

Recurrence, Neoplasms, Plasma Cell

NCT07077798 2025-07-22

Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection

234 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT06993506 2025-05-29

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

500 enrolled

Neoplasm Metastasis, Recurrence

NCT06982690 2025-05-21

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

370 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Recurrence

NCT04275102 2025-05-15

Three Times Weekly Symptom Screening for Children With Cancer

30 enrolled

Neoplasms, Recurrence

NCT06880601 2025-04-03

TALIM

52 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT06788600 2025-04-02

WGc-043

15 enrolled

Lymphoid

Lymphoma, Recurrence

NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

600 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

NCT06837389 2025-02-20

Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors

18 enrolled

Recurrence, Hematologic Neoplasms

NCT06791616 2025-01-24

Surveillance Intervals After Piecemeal Resection of Non-pedunculated Colorectal Lesions ≥20mm

746 enrolled

Colonic Polyps, Recurrence, Colorectal Neoplasms

NCT06754540 2025-01-17

Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

51 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT06750952 2024-12-27

iTHYM

24 enrolled

Recurrence, Thymus Neoplasms

NCT06751277 2024-12-27

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

26 enrolled

Gynecologic

Recurrence, Endometrial Neoplasms

NCT06648200 2024-10-18

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Phase 1 Not yet recruiting

100 enrolled

Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT06647329 2024-10-17

CAR-T Therapy

30 enrolled

Lymphoid

Lymphoma, Recurrence

NCT06641648 2024-10-15

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

Phase 1 Not yet recruiting

12 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT06449846 2024-06-10

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

152 enrolled

Carcinoma, Hepatocellular, Recurrence, Neoplasm, Residual

NCT06385808 2024-04-26

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

37 enrolled